Phosbind Biotin for Dynamic Phosphorylation Mapping
2026-09-08
Phosbind Biotin can extend Western Blot detection of phosphorylated proteins from a single target assay to dynamic pathway analysis. This article uses the OsCPK4–OsCNGC7 rice salt-response study to explain what phosphate-capture data can reveal, and where orthogonal validation remains essential.
WSP-5 for Live-Cell H2S Imaging
2026-09-08
WSP-5 converts hydrogen sulfide reactivity into a rapid turn-on fluorescence signal, enabling spatial and time-resolved measurements that bulk assays can miss. This guide translates diabetic cardiomyopathy findings into practical workflows for endogenous H2S, donor-release experiments, and live-cell optimization.
Isorhamnetin and PI3K/Akt-Driven Oocyte Maturation
2026-09-07
The reference study identifies Isorhamnetin as a dietary flavonoid that improves porcine oocyte maturation at an experimentally defined concentration by activating PI3K/Akt signaling. Its findings connect improved polar body extrusion with lower oxidative stress, reduced apoptosis, better mitochondrial homeostasis, and attenuation of endoplasmic reticulum stress, while also defining important limits for translation.
Dabigatran Etexilate: Direct Thrombin Inhibitor Research
2026-09-05
Dabigatran etexilate is an oral prodrug and direct thrombin inhibitor used to study thrombin-dependent coagulation, platelet activation, and stroke prevention in atrial fibrillation. Its defined thrombin affinity, plasma clotting activity, and handling specifications support reproducible anticoagulant research when prodrug conversion and solvent effects are controlled.
Reactive Oxygen Species Assay Kit Workflow
2026-09-05
Build a reproducible live-cell ROS workflow with DCFH-DA, positive-control validation, and practical normalization strategies. The assay is especially useful for connecting treatment-induced oxidative stress with apoptosis, DNA damage, and radiosensitization studies.
NETs, CML, and Differential TKI Effects
2026-09-04
The reference study shows that neutrophil extracellular trap formation is elevated in chronic myeloid leukemia and is altered differentially by tyrosine kinase inhibitors. Its combination of patient-derived neutrophils, a BCR-ABL1-transduced differentiation model, and pathway-directed perturbation provides a useful framework for studying how leukemia biology may intersect with treatment-associated vascular risk.
Inflammation in Ischemic Stroke: Biomarkers to Therapy
2026-09-04
This 2025 Frontiers in Immunology review integrates the temporal, cellular, and systemic dimensions of inflammation after ischemic stroke, linking inflammatory biomarkers with diagnosis, prognosis, and treatment research. Its main value is a coherent biomarker-to-therapy framework that also clarifies why timing, blood–brain barrier status, and peripheral immune signaling matter when translating findings into clinical or experimental strategies.
Chlorin e6 (Ce6): PDT Mechanism and Uses
2026-09-03
Chlorin e6 is a Ce6 photosensitizer that converts light activation into reactive oxygen species generation for anticancer photodynamic therapy and antibacterial research. Product specifications and preclinical evidence support controlled, light-dependent workflows, but dose, irradiation, formulation, and biological context must be validated independently.
4-Ethylphenyl Sulfate: From Signal to Mechanism
2026-09-03
4-Ethylphenyl sulfate connects renal toxin retention with gut microbiota-brain interaction research. This guide presents an adsorption-aware framework for interpreting biomarker, neurobehavioral, and mechanistic assays without confusing analytical signal with biological causality.
Telmisartan Workflows for Cardiac Hypertrophy
2026-09-02
Use Telmisartan as a defined AT1-receptor blockade control to separate upstream angiotensin II signaling from downstream RIP3/CaMKII, JAK2/STAT3, and NF-κB responses. This workflow combines practical DMSO handling, dose-response design, orthogonal cardiac readouts, and troubleshooting for reproducible cardiovascular disease research.
Ribonuclease R for Circular RNA Validation
2026-09-02
Use RNase R (20 U/μL) to reduce linear RNA background and strengthen circular RNA validation by combining enzymatic enrichment with junction-specific assays. This workflow translates a pulpitis circRNA mechanism into practical choices for qPCR, RNA structure analysis, stability experiments, and sequencing preparation.
Ac-YVAD-CMK Maps Pyroptosis in Liver Inflammation
2026-09-01
Ac-YVAD-CMK is an irreversible caspase-1 inhibitor for separating membrane injury from cytokine-driven pyroptosis in liver inflammation models. This article translates TMEM16F–Kupffer cell findings into a practical assay framework for interpreting IL-1β and IL-18 release.
Elobixibat hydrate: IBAT Assays and Motility
2026-09-01
Elobixibat hydrate provides a selective way to connect ileal bile acid transport with colonic signaling, secretion, and motility. This workflow combines bile acid biology with pressure-threshold peristalsis assays to support constipation, colonoscopy-preparation, and metabolic research while highlighting key translational limits.
AT13387: Hsp90 Inhibition for Translational Biology
2026-08-31
AT13387 offers translational researchers a mechanistically distinctive way to interrogate Hsp90 chaperone inhibition, client-protein destabilization, oncogenic signaling collapse, cell cycle arrest, and apoptosis induction. This thought-leadership perspective connects Hsp90 biology with emerging lessons from NINJ1-mediated protein release while clearly separating evidence from hypothesis and outlining rigorous cancer biology research workflows.
Maraviroc (UK-427857) Research Workflows
2026-08-30
Maraviroc provides a nanomolar, CCR5-focused way to dissect HIV-1 entry, viral tropism, and chemokine signaling. The same target logic can support carefully controlled neuroinflammation studies, provided researchers separate established antiviral evidence from hypothesis-generating stroke applications.
462 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page